Collagen Solutions PLC Director/PDMR Shareholding (9947K)
July 13 2017 - 6:39AM
UK Regulatory
TIDMCOS
RNS Number : 9947K
Collagen Solutions PLC
13 July 2017
'This announcement contains inside information.'
Collagen Solutions Plc
(the "Company")
Director/PDMR Dealing
Collagen Solutions plc (AIM: COS), the developer and
manufacturer of medical grade collagen components for use in
regenerative medicine, medical devices and in-vitro diagnostics,
announces that Options over ordinary shares of 1p each, as noted
below in the Company ("Ordinary Shares") were granted on 12 July
2017.
The Options have an exercise period of ten years from grant and
have an exercise price per Option of 5.25p. The Options vest in
full after the normal vesting date of 12 July 2020, upon the
closing middle market price per Ordinary Share achieving 10p and
positive cash flow from operations being sustained for a period of
six months.
Director/PDMR Position Number of
Ordinary
Shares options
granted
Chief Executive
Jamal Rushdy Officer 1,700,000
Chief Financial
Gillian Black Officer 1,700,000
PDMR / VP Global
Christian Wattengel R&D 500,000
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------------
a) Name 1. Jamal Rushdy
2. Gillian Black
3. Christian Wattengel
--- ------------------------- ---------------------------------
2 Reason for the notification
--- ------------------------------------------------------------
a) Position/status 1. Chief Executive Officer
2. Chief Financial Officer
3. PDMR / VP Global R&D
--- ------------------------- ---------------------------------
b) Initial notification Initial
/Amendment
--- ------------------------- ---------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ------------------------------------------------------------
a) Name Collagen Solutions Plc
--- ------------------------- ---------------------------------
b) LEI N/a
--- ------------------------- ---------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ------------------------------------------------------------
a) Description of Option to acquire 1p ordinary
the financial shares in Collagen Solutions
instrument, type Plc
of instrument
N/a
Identification
code
--- ------------------------- ---------------------------------
b) Nature of the Grant of options
transaction
--- ------------------------- ---------------------------------
c) Price(s) and volume(s) Price (exercise) Volume(s)
------------------ ----------
1. 5.25p per
share 1,700,000
------------------ ----------
2. 5.25p per
share 1,700,000
------------------ ----------
3. 5.25p per
share 500,000
------------------ ----------
--- ------------------------- ---------------------------------
d) Aggregated information
- Aggregated volume N/a
- Price N/a
--- ------------------------- ---------------------------------
e) Date of the transaction 12 July 2017
--- ------------------------- ---------------------------------
f) Place of the transaction Outside a trading venue
--- ------------------------- ---------------------------------
About Collagen Solutions:
Collagen Solutions Plc is a global provider of medical grade
collagen formulations and components for use in regenerative
medicine, medical devices and in-vitro diagnostics and research.
The capabilities of the Company include the provision of native,
soluble and powdered collagen formulations, processed and
semi-processed tissues such as pericardium, bone, and blood
vessels, and expertise in the development and contract manufacture
of collagen components for use as engineered tissue scaffolds and
other medical devices. These products are used in a wide variety of
applications including orthopaedics, cardiovascular, dental,
plastic surgery, wound healing, neurology and urology. Collagen
Solutions' unique offering extends beyond material supply and
contract services through the highly skilled staff who support
customers through the various stages of development and regulatory
approval. For additional information, please visit
www.collagensolutions.com.
Enquiries:
Collagen Solutions Plc Contact via Walbrook
Jamal Rushdy, Chief Executive
Officer
Gill Black, Chief Financial
Officer
Cenkos Securities plc (Nominated Tel: 0207 397 8900
Adviser and Broker)
Stephen Keys
Steve Cox
Callum Davidson
Walbrook PR Tel: 020 7933 8780 or collagen@walbrookpr.com
Mike Wort Mob: 07900 608 002
Anna Dunphy Mob: 07876 741 001
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHOKNDNKBKDFOD
(END) Dow Jones Newswires
July 13, 2017 06:39 ET (10:39 GMT)
Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2024 to May 2024
Collagen Solutions (LSE:COS)
Historical Stock Chart
From May 2023 to May 2024